Effects of Dapagliflozin on Body Composition and Liver Tests in Patients with Nonalcoholic Steatohepatitis Associated with Type 2 Diabetes Mellitus: A Prospective, Open-label, Uncontrolled Study

BACKGROUND: Nonalcoholic steatohepatitis (NASH) is an active form of nonalcoholic fatty liver disease. Risk factors for NASH include type 2 diabetes mellitus (T2DM) and obesity. Sodium–glucose cotransporter 2 (SGLT2) inhibitors used to treat T2DM prevent glucose reabsorption in the kidney and increa...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Curr Ther Res Clin Exp
Hlavní autoři: Tobita, Hiroshi, Sato, Shuichi, Miyake, Tatsuya, Ishihara, Shunji, Kinoshita, Yoshikazu
Médium: Artigo
Jazyk:Inglês
Vydáno: Elsevier 2017
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5587885/
https://ncbi.nlm.nih.gov/pubmed/28912902
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.curtheres.2017.07.002
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky